Threonine

Drug profile

Key facts

Threonine is a drug catalogued in DrugCentral. Recorded indications include Nutritional support.

• Indications: Nutritional support.
• Molecular formula: C4H9NO3; molecular weight 119.12 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

• Nutritional support

Contraindications (1)

• Classical phenylketonuria

Regulatory approvals (1)

Date	Agency	Marketed as	Applicant	Orphan
—	FDA	—	—

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA term	LLR
Foetal growth restriction	66.6

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Threonine is on its molecule page.

• Molecular formula: C₄H₉NO₃
• Molecular weight: 119.12 g/mol
• CAS number: 72-19-5
• InChIKey: AYFVYJQAPQTCCC-GBXIJSLDSA-N
• PubChem CID: 6288

C[C@@H](O)[C@H](N)C(O)=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Threonine used for?

DrugCentral lists the following indications for Threonine: Nutritional support.

What is the chemical formula of Threonine?

Threonine has the molecular formula C4H9NO3 and a molecular weight of 119.12 g/mol.

Sources

• DrugCentral drug card 4254 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL291747 — compound record and bioactivity
• PubChem CID 6288 — chemical identifiers
• DrugBank DB00156 — drug record
• FDA UNII 2ZD004190S — substance identity
• DailyMed: FDA labels for Threonine — current prescribing information (label search)
• FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral

How this page is built: methodology · editorial policy & corrections.